Advertisement
UK markets close in 7 hours 5 minutes
  • FTSE 100

    8,289.66
    +76.17 (+0.93%)
     
  • FTSE 250

    20,362.24
    +197.70 (+0.98%)
     
  • AIM

    776.70
    +5.17 (+0.67%)
     
  • GBP/EUR

    1.1650
    -0.0009 (-0.08%)
     
  • GBP/USD

    1.2538
    -0.0025 (-0.20%)
     
  • Bitcoin GBP

    51,262.62
    -713.18 (-1.37%)
     
  • CMC Crypto 200

    1,319.09
    -46.04 (-3.37%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.58
    +0.10 (+0.13%)
     
  • GOLD FUTURES

    2,321.90
    -9.30 (-0.40%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,228.71
    +53.50 (+0.29%)
     
  • CAC 40

    8,007.49
    +10.85 (+0.14%)
     

Exclusive: Beauty industry supplier Knowlton readies IPO - sources

By Joshua Franklin

(Reuters) - Buyout firm Cornell Capital is preparing a U.S. initial public offering (IPO) of Knowlton Development Corp (KDC), which could value the manufacturer and custom formulator of products for the beauty industry at more than $5 billion, according to people familiar with the matter.

Cornell Capital has hired Goldman Sachs Group Inc to lead KDC's IPO, which may raise around $750 million and come later this year, the sources said, requesting anonymity as the matter is private.

The sources cautioned that the IPO plans are subject to market conditions. Cornell Capital and Goldman Sach declined to comment.

ADVERTISEMENT

Longueuil, Québec-based KDC, operates under the brand name KDC/ONE, and provides manufacturing and packaging services to beauty and personal care companies.

The IPO plans come at a challenging time for the $500 billion global beauty industry, as people stay home during the COVID-19 pandemic. This has affected demand for makeup products, though the personal care sector, which includes products such as bath soap and shampoo, has performed better.

Industry executives have talked about a broader recovery for the sector once COVID-19 vaccines are largely available.

Cornell led an investor group to buy KDC in 2018 and since then has purchased a string of add-on companies to help expand it, including HCT Group and Zobele Group.

(Reporting by Joshua Franklin in Miami; editing by Jonathan Oatis)